Medical Biotechnology MCQs (Set-1)

Difficulty: Easy & Basic

Recombinant human insulin is made by

A converting glucose directly into insulin
B expressing the human insulin gene in a production host such as bacteria or yeast
C extracting insulin from plant cellulose
D fusing insulin with a red blood cell

A monoclonal antibody is defined by its

A single-clone origin and defined antigen specificity
B ability to bind every antigen in a sample
C production only in plant cells
D lack of a variable region

ELISA detects a target by combining

A specific antigen–antibody binding with an enzyme-linked signal
B cell sorting by size alone
C chromosome separation in a gel
D DNA sequencing with fluorescent nucleotides only

In a sandwich ELISA, the sample analyte is typically captured between

A a capture antibody and a detection antibody
B two DNA primers
C a virus and a host chromosome
D a plasmid and a ribosome

PCR is used in medical biotechnology primarily to

A amplify a selected DNA sequence
B separate antibodies by size
C translate a protein into DNA
D remove a mutation from a patient’s cells

When the starting target is RNA, which step is needed before conventional PCR amplification?

A protein denaturation only
B ligation into a chromosome
C translation into protein
D reverse transcription to make complementary DNA

A vaccine made from a purified pathogen protein is a

A subunit vaccine
B monoclonal assay
C live-cell therapy
D DNA microarray

An mRNA vaccine gives cells instructions to

A rewrite every chromosome permanently
B make antibodies without immune cells
C produce a selected antigen temporarily
D turn mRNA into a bacterial plasmid

Gene therapy aims to

A separate proteins by electrophoresis
B culture bacteria to make antibiotics only
C modify or deliver genetic material to treat or prevent disease
D measure blood pressure with a cuff

CAR-T cell therapy involves

A adding antibodies to red blood cells
B transferring a plant chloroplast into a tumor
C using PCR to amplify an entire person’s genome
D engineering a patient’s or donor’s T cells to recognize a target through a chimeric antigen receptor

A biosensor combines a biological recognition element with

A a culture medium that produces antibodies
B a transducer that converts recognition into a measurable signal
C a centrifuge that copies DNA
D a microscope that changes genes

Pharmacogenomics studies how

A bacterial growth affects blood type
B antibodies change a drug’s color
C genetic variation can influence drug response
D weather changes vaccine storage

A DNA microarray can compare expression of many known genes by

A counting red blood cells
B hybridizing labeled nucleic acids to complementary probes
C sequencing each whole chromosome one base at a time
D measuring only protein concentration

Which test can directly detect a protein and provide information about its approximate size?

A PCR
B DNA microarray
C karyotyping
D Western blot

A recombinant therapeutic protein is produced in cultured mammalian cells when

A no protein purification is needed
B the cells must be bacteria
C post-translational processing or complex folding is important
D the protein is a short DNA primer

What does a positive antibody test usually show?

A the sample contains antibodies that bind the test target
B the pathogen’s genome is necessarily present in the sample
C the test has no chance of cross-reactivity
D the person is always infectious

An antigen test is designed to detect

A a change in chromosome number
B the patient’s memory B cells only
C a component of a pathogen or other target directly
D the response of a drug-metabolizing enzyme

In ex vivo gene therapy, cells are

A never removed from the body
B modified outside the body and then returned to the patient
C grown in a plant leaf
D edited only inside the germline

A viral vector in gene therapy is used mainly to

A replace cell-culture media
B destroy all host DNA
C measure antibody concentration
D deliver a genetic payload into target cells

A stem cell’s ability to self-renew means it can

A differentiate only into one mature type
B never divide
C divide to produce more stem cells while retaining its state
D make a vaccine antigen by itself

An iPSC is produced by

A turning a DNA sequence into a protein
B reprogramming a differentiated cell to a pluripotent-like state
C removing all mitochondria from an embryo
D fusing an antibody with a myeloma cell

A molecular diagnostic test may identify

A only a patient’s height
B all future disease with certainty
C only the color of a sample
D a pathogen nucleic acid or a disease-associated genetic variant

A recombinant hepatitis B vaccine uses

A a patient’s own antibodies
B a pathogen antigen produced by recombinant expression
C a complete infectious hepatitis B virus in every dose
D a bacterial chromosome fragment that causes disease

Therapeutic monoclonal antibodies are used because they can

A detect every mutation in a genome
B replace all immune cells
C bind a specific target involved in disease
D amplify DNA without primers

Quality testing of a cell-therapy product may include checks for

A the size of the incubator door
B only the label’s color
C the donor’s handwriting
D identity, viability, potency, and contamination